<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01527617</url>
  </required_header>
  <id_info>
    <org_study_id>IRB10178</org_study_id>
    <nct_id>NCT01527617</nct_id>
  </id_info>
  <brief_title>Effect of Chronic Consumption of a Cranberry Beverage on Inflammation and Oxidative Stress</brief_title>
  <official_title>The Effect of Chronic Consumption of a Cranberry Beverage on Inflammation and Oxidative Stress in Healthy But Overweight/Obese Subjects: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tufts University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Washington State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ocean Spray, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Tufts University</source>
  <brief_summary>
    <textblock>
      The objective of this randomized, double-blind, placebo-controlled, parallel-design clinical
      trial is to investigate the potential antioxidant benefits of a cranberry beverage. The
      investigators hypothesize the chronic consumption of this beverage will improve indices of
      oxidative stress, inflammation, endothelial function, and glucoregulation. The investigators
      also hypothesize that these benefits will be particularly evident following an oral glucose
      tolerance test.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in biomarkers of inflammation compared with placebo</measure>
    <time_frame>Baseline and 8 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in biomarkers of oxidative stress compared with placebo.</measure>
    <time_frame>Baseline and 8 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">79</enrollment>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>Cranberry beverage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-cranberry beverage</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cranberry</intervention_name>
    <description>beverage containing cranberry at a dose of 15.2 ounces per day for 56 days.</description>
    <arm_group_label>Cranberry beverage</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-Cranberry beverage</intervention_name>
    <description>Placebo Comparator - beverage absent cranberry at a dose of 15.2 ounces per day for 56 days.</description>
    <arm_group_label>Non-cranberry beverage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men &amp; women, aged 30-70 years

          -  BMI 27-34.9 kg/m2

          -  waist:hip ratio &gt; 0.8 for women and &gt; 0.9 for men

        Exclusion Criteria:

          -  Cigarette smoking and/or nicotine replacement use within last 6 months

          -  Individuals taking estrogen or testosterone

          -  Use of cholesterol-lowering medications

          -  Use of blood pressure-lowering medications

          -  Regular use (&gt; 1x/wk) of any stomach acid-lowering medications or laxatives (including
             fiber supplements)

          -  Cardiovascular (heart) disease

          -  Gastrointestinal disease

          -  Kidney disease

          -  Endocrine disease: including diabetes, untreated thyroid disease

          -  Rheumatoid arthritis

          -  Immune deficiency conditions

          -  Active treatment for any type of cancer, except basal cell carcinoma, within 1 year
             prior to study admission

          -  Systolic blood pressure &gt; 139 mmHg and/or diastolic blood pressure &gt; 89 mmHg

          -  Regular use of systemic steroids, oral or injectable

          -  Regular daily intake of ≥ 2 alcoholic drinks

          -  Infrequent (&lt; 3/week) or excessive (&gt; 3/d) number of regular bowel movements

          -  Gain or loss of ≥ 5% of body weight in the last 6 months

          -  Pregnancy

          -  Strict vegetarians

          -  No dietary supplements, including those containing any vitamins, minerals, herbs,
             plant concentrates (including garlic, gingko, St. John's wort) homeopathic remedies,
             probiotics, or fish oil (including cod liver oil), for one month prior to study
             admission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington State University</name>
      <address>
        <city>Pullman</city>
        <state>Washington</state>
        <zip>99164</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2012</study_first_submitted>
  <study_first_submitted_qc>February 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2012</study_first_posted>
  <last_update_submitted>June 1, 2016</last_update_submitted>
  <last_update_submitted_qc>June 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

